Table 1b. Pathways affected by vitamin D supplementation.
Signal Pathway | odds radio (loge) | p value | Adjusted p value | |
---|---|---|---|---|
Up regulated | ||||
Metabolism of xenobiotics by P450 | 2.58 | <0.0001 | <0.0001 | |
Drug metabolism - P450 | 2.87 | <0.0001 | <0.0001 | |
Metabolic pathways | 1.20 | <0.0001 | <0.0001 | |
Primary bile acid biosynthesis | 3.39 | <0.0001 | <0.0001 | |
PPAR signaling pathway | 2.53 | <0.0001 | <0.0001 | |
Glycosphingolipid biosynthesis | 2.85 | 0.0017 | 0.0192 | |
Retinol metabolism | 2.97 | <0.0001 | <0.0001 | |
Linoleic acid metabolism | 3.33 | <0.0001 | <0.0001 | |
Drug metabolism | 2.36 | <0.0001 | 0.0003 | |
Arachidonic acid metabolism | 2.40 | <0.0001 | <0.0001 | |
Down regulated | ||||
Retinol metabolism | 1.90 | 0.0005 | 0.0265 | |
ABC transporters | 2.19 | 0.0005 | 0.0265 | |
Biosynthesis of unsaturated fatty acids | 2.21 | 0.0017 | 0.0449 | |
Tyrosine metabolism | 2.38 | 0.0002 | 0.0265 | |
Focal adhesion | 1.33 | 0.0011 | 0.0337 | |
Taste transduction | 1.83 | 0.0020 | 0.0470 | |
mTOR signaling pathway | 2.15 | 0.0006 | 0.0265 | |
Glycosaminoglycan biosynthesis | 3.02 | 0.0010 | 0.0337 |